-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Rayont Inc- RAYT- Announces the Appointment of Ms. Ilenna Copley as its Chief Operating Officer.
Rayont Inc- RAYT- Announces the Appointment of Ms. Ilenna Copley as its Chief Operating Officer.
Palo Alto, California, May 20, 2022 (GLOBE NEWSWIRE) -- Rayont Inc. ("Rayont" or the "Company") (OTC PINK: RAYT), an international healthcare company specializing in the manufacturing, distribution of alternative medicine products and services across the entire value chain, announced that on 16 of May 2022 it appointed Ms. Ilenna Copley as its Chief Operating Officer.
In this new role, Ms. Copley will oversee business operations, business strategy, corporate governance, investor relations and third-party engagements. Ms. Copley is an experienced executive business advisor with a strategic business and entrepreneurial mind, together with strong capabilities in simultaneously managing multiple major initiatives.
For over 20 years, Ms. Copley has provided legal and commercial advice to Boards and C-Suite executives, from major businesses to start ups, with a focus on achieving optimal strategic outcomes on a financially astute basis, while mitigating risk.
Ms. Copley began her legal career as an Associate to a Justice of the Supreme Court of Queensland, Australia, and progressed to Special Counsel at a top tier law firm, where she maintained a dual focus practice of commercial advisory and major dispute resolution work.
She has extensive commercial and legal experience across multiple sectors, including general commercial, mining, energy and resources, infrastructure, pharmaceuticals, technology including Blockchain, finance, investment, environment, agribusiness, sport, media, government and humanitarian.
"We are delighted Ilenna is joining Rayont Inc. in a leadership role," said Rayont's President & CEO, Ms Marshini Aliya Moodley. "Ilenna's multifaceted capabilities and experience will comprehensively serve the commercial interests and vision for the future of Rayont Inc., including as it continues to expand its operations into new markets."
About Rayont Inc.
Rayont, Inc. (RAYT) is a public traded company incorporated in Nevada, USA since its inception in 2011. In 2018, the Company repositioned itself to focus on healthcare including the manufacturing, distribution of alternative medicine products and services across the entire value chain.
Longer term, it has also invested in a ground-breaking cancer treatment technology through an exclusive license arrangement for the Sub-Saharan African territories.
Headquartered in Australia with expanding operations internationally, Rayont`s purpose is "Making Natural Products to Improve People`s Health". We do this by investing in early research and development, establishing high quality manufacturing assets for regional distribution and operating across the alternative medicine value chain.
Our underlying strategy is to grow organically, selectively acquire, scale profitable assets and improve efficiency through digitalization.
For further information, please visit
SAFE HARBOR
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933, are subject to Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbors created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and other results and further events could differ materially from those anticipated in such statements. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.
Company Contact:
Investor Relations
ir@rayont.com
Palo Alto, California, May 20, 2022 (GLOBE NEWSWIRE) -- Rayont Inc. ("Rayont" or the "Company") (OTC PINK: RAYT), an international healthcare company specializing in the manufacturing, distribution of alternative medicine products and services across the entire value chain, announced that on 16 of May 2022 it appointed Ms. Ilenna Copley as its Chief Operating Officer.
加利福尼亞州帕洛阿爾託,2022年5月20日(Global Newswire)--Rayont Inc.(以下簡稱“Rayont”或“公司”)(場外交易市場代碼:RAYT)是一家專門從事替代醫學產品和服務在整個價值鏈上的製造、分銷的國際醫療保健公司,該公司於2022年5月16日宣佈任命Ilenna Copley女士為首席運營官。
In this new role, Ms. Copley will oversee business operations, business strategy, corporate governance, investor relations and third-party engagements. Ms. Copley is an experienced executive business advisor with a strategic business and entrepreneurial mind, together with strong capabilities in simultaneously managing multiple major initiatives.
在這一新職位上,科普利女士將負責業務運營、業務戰略、公司治理、投資者關係和第三方活動。科普利女士是一位經驗豐富的執行業務顧問,具有戰略業務和企業家精神,並具有同時管理多項重大計劃的強大能力。
For over 20 years, Ms. Copley has provided legal and commercial advice to Boards and C-Suite executives, from major businesses to start ups, with a focus on achieving optimal strategic outcomes on a financially astute basis, while mitigating risk.
20多年來,科普利女士一直為董事會和高管提供法律和商業建議,從大企業到初創企業,專注於在精明的財務基礎上實現最佳戰略結果,同時降低風險。
Ms. Copley began her legal career as an Associate to a Justice of the Supreme Court of Queensland, Australia, and progressed to Special Counsel at a top tier law firm, where she maintained a dual focus practice of commercial advisory and major dispute resolution work.
Copley女士以澳大利亞昆士蘭州最高法院法官助理的身份開始了她的法律生涯,並在一家頂級律師事務所晉升為特別顧問,在那裏她保持着商業諮詢和重大糾紛解決工作的雙重重點。
She has extensive commercial and legal experience across multiple sectors, including general commercial, mining, energy and resources, infrastructure, pharmaceuticals, technology including Blockchain, finance, investment, environment, agribusiness, sport, media, government and humanitarian.
她在多個行業擁有豐富的商業和法律經驗,包括一般商業、採礦、能源和資源、基礎設施、製藥、技術(包括區塊鏈)、金融、投資、環境、農業綜合企業、體育、媒體、政府和人道主義。
"We are delighted Ilenna is joining Rayont Inc. in a leadership role," said Rayont's President & CEO, Ms Marshini Aliya Moodley. "Ilenna's multifaceted capabilities and experience will comprehensively serve the commercial interests and vision for the future of Rayont Inc., including as it continues to expand its operations into new markets."
Rayont總裁兼首席執行官Marshini Aliya Moodley女士表示:“我們很高興Ilenna加入Rayont Inc.擔任領導職務。”Ilenna的多方面能力和經驗將全面服務於Rayont Inc.的商業利益和未來願景,包括在它繼續將業務擴展到新市場的時候。“
About Rayont Inc.
關於人造絲Inc.
Rayont, Inc. (RAYT) is a public traded company incorporated in Nevada, USA since its inception in 2011. In 2018, the Company repositioned itself to focus on healthcare including the manufacturing, distribution of alternative medicine products and services across the entire value chain.
Rayont,Inc.(RAYT)是一家上市公司,自2011年成立以來一直在美國內華達州成立。2018年,該公司重新定位,專注於醫療保健,包括在整個價值鏈上製造、分銷替代藥物產品和服務。
Longer term, it has also invested in a ground-breaking cancer treatment technology through an exclusive license arrangement for the Sub-Saharan African territories.
從長遠來看,它還通過撒哈拉以南非洲領土的獨家許可安排投資了一項突破性的癌症治療技術。
Headquartered in Australia with expanding operations internationally, Rayont`s purpose is "Making Natural Products to Improve People`s Health". We do this by investing in early research and development, establishing high quality manufacturing assets for regional distribution and operating across the alternative medicine value chain.
總部設在澳大利亞,業務在國際上不斷擴大,雷蒙德的宗旨是“製造天然產品增進人們的健康”。我們通過投資於早期研發、為區域分銷建立高質量的製造資產以及跨替代藥物價值鏈運營來做到這一點。
Our underlying strategy is to grow organically, selectively acquire, scale profitable assets and improve efficiency through digitalization.
我們的基本戰略是通過數字化實現有機增長、有選擇地收購、擴大盈利資產規模並提高效率。
For further information, please visit
如需進一步資料,請瀏覽
SAFE HARBOR
安全港
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933, are subject to Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbors created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and other results and further events could differ materially from those anticipated in such statements. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.
本新聞稿中的某些陳述可能包含1933年《證券法》第175條規定的前瞻性信息,受1934年《證券交易法》第3b-6條的約束,並受這些規定所創造的安全港的約束。本新聞稿中包含的除事實陳述外的所有陳述,包括但不限於有關公司潛在的未來計劃和目標的陳述,均為前瞻性陳述,涉及風險和不確定性。不能保證這樣的陳述將被證明是準確的,其他結果和進一步的事件可能與這種陳述中預期的大不相同。未來的事件和實際結果可能與前瞻性陳述中陳述的、預期的或潛在的大不相同。
Company Contact:
Investor Relations
ir@rayont.com
公司聯繫人:
投資者關係
郵箱:ir@rayont.com
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧